Shifting of Registered Office from one State to another.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025, with auditors (S S Kothari Mehta & Co. LLP) issuing an unmodified opinion. FY25 continuing operations revenue grew to Rs. 2,234.06 lakhs from Rs. 1,447.13 lakhs (restated) in FY24, about 54% higher. However, the company reported an exceptional loss of Rs. 37,494.57 lakhs due to a demerger scheme under which the Insoluble Sulphur & Chemicals business was transferred to OCCL Limited effective July 1, 2024, leading to a standalone net loss of Rs. 36,634.01 lakhs versus a profit of Rs. 4,629.36 lakhs in FY24 (restated). Total assets fell sharply from Rs. 84,195.73 lakhs to Rs. 26,565.57 lakhs reflecting the demerger, and EPS turned deeply negative at Rs. (366.70). The board also approved voluntary delisting from NSE, shifting the registered office from Gujarat to another state, appointment of a new Additional Director (Mrs. Mitali Gupta), and re-appointment of Internal and Secretarial Auditors.
Shareholders should note the steep reported loss is largely an accounting outcome of the demerger rather than ongoing operational weakness, but EPS turned sharply negative and equity base was reduced. Voluntary delisting from NSE means reduced trading liquidity for shareholders holding on NSE; the registered office shift and new appointments are administrative. Investors should watch for the delisting exit price mechanism and any subsequent corporate actions by the resulting entity (OCCL Limited).